P K Jacobsen

Summary

Affiliation: University of Copenhagen
Country: Denmark

Publications

  1. ncbi request reprint Dual blockade of the renin-angiotensin system in type 1 patients with diabetic nephropathy
    Peter Jacobsen
    Steno Diabetes Center, Gentofte, Denmark
    Nephrol Dial Transplant 17:1019-24. 2002
  2. ncbi request reprint Time to consider ACE insertion/deletion genotypes and individual renoprotective treatment in diabetic nephropathy?
    P K Jacobsen
    Steno Diabetes Center, Gentofte, Denmark
    Kidney Int 69:1293-5. 2006
  3. ncbi request reprint Preventing end-stage renal disease in diabetic patients - dual blockade of the renin-angiotensin system (Part II)
    Peter Karl Jacobsen
    Steno Diabetes Center, Gentofte, Denmark
    J Renin Angiotensin Aldosterone Syst 6:55-68. 2005
  4. ncbi request reprint Preventing end stage renal disease in diabetic patients--genetic aspect (part I)
    Peter Karl Jacobsen
    Steno Diabetes Center, Gentofte, Denmark
    J Renin Angiotensin Aldosterone Syst 6:1-14. 2005
  5. ncbi request reprint Single versus dual blockade of the renin-angiotensin system (angiotensin-converting enzyme inhibitors and/or angiotensin II receptor blockers) in diabetic nephropathy
    Peter Jacobsen
    Steno Diabetes Center, Gentofte, Denmark
    Curr Opin Nephrol Hypertens 13:319-24. 2004
  6. ncbi request reprint Genetic variation in the Renin-Angiotensin system and progression of diabetic nephropathy
    Peter Jacobsen
    Steno Diabetes Center, Gentofte, Denmark
    J Am Soc Nephrol 14:2843-50. 2003
  7. ncbi request reprint Effect of short-term hyperglycaemia on haemodynamics in type 1 diabetic patients
    P Jacobsen
    Steno Diabetes Center, Gentofte, Denmark
    J Intern Med 254:464-71. 2003
  8. ncbi request reprint Dual blockade of the renin-angiotensin system versus maximal recommended dose of ACE inhibition in diabetic nephropathy
    Peter Jacobsen
    Steno Diabetes Center, Gentofte, Denmark
    Kidney Int 63:1874-80. 2003
  9. ncbi request reprint Additive effect of ACE inhibition and angiotensin II receptor blockade in type I diabetic patients with diabetic nephropathy
    Peter Jacobsen
    Steno Diabetes Center, Gentofte, Denmark and Faculty of Health Science, University of Aarhus, Denmark
    J Am Soc Nephrol 14:992-9. 2003
  10. doi request reprint Effect of adjunct metformin treatment on levels of plasma lipids in patients with type 1 diabetes
    S S Lund
    Steno Diabetes Center, Niels Steensens Vej 2, 2820 Gentofte, Denmark
    Diabetes Obes Metab 11:966-77. 2009

Collaborators

Detail Information

Publications11

  1. ncbi request reprint Dual blockade of the renin-angiotensin system in type 1 patients with diabetic nephropathy
    Peter Jacobsen
    Steno Diabetes Center, Gentofte, Denmark
    Nephrol Dial Transplant 17:1019-24. 2002
    ..We tested the effect of dual blockade of the renin-angiotensin system (RAS) in these patients...
  2. ncbi request reprint Time to consider ACE insertion/deletion genotypes and individual renoprotective treatment in diabetic nephropathy?
    P K Jacobsen
    Steno Diabetes Center, Gentofte, Denmark
    Kidney Int 69:1293-5. 2006
    ..This Commentary summarizes the impact of the angiotensin-converting enzyme (ACE) insertion/deletion polymorphism in the ACE gene on initiation and progression of diabetic nephropathy...
  3. ncbi request reprint Preventing end-stage renal disease in diabetic patients - dual blockade of the renin-angiotensin system (Part II)
    Peter Karl Jacobsen
    Steno Diabetes Center, Gentofte, Denmark
    J Renin Angiotensin Aldosterone Syst 6:55-68. 2005
    ..Trials using primary renal endpoints in diabetic nephropathy are still needed, and will finally establish the role of dual blockade of the RAS in a clinical setting...
  4. ncbi request reprint Preventing end stage renal disease in diabetic patients--genetic aspect (part I)
    Peter Karl Jacobsen
    Steno Diabetes Center, Gentofte, Denmark
    J Renin Angiotensin Aldosterone Syst 6:1-14. 2005
    ..As new genetic approaches and methods develop, further understanding of diabetic nephropathy will evolve and genotyping will help prevent ESRD in diabetic patients...
  5. ncbi request reprint Single versus dual blockade of the renin-angiotensin system (angiotensin-converting enzyme inhibitors and/or angiotensin II receptor blockers) in diabetic nephropathy
    Peter Jacobsen
    Steno Diabetes Center, Gentofte, Denmark
    Curr Opin Nephrol Hypertens 13:319-24. 2004
    ....
  6. ncbi request reprint Genetic variation in the Renin-Angiotensin system and progression of diabetic nephropathy
    Peter Jacobsen
    Steno Diabetes Center, Gentofte, Denmark
    J Am Soc Nephrol 14:2843-50. 2003
    ..Interaction between polymorphisms in the renin-angiotensin system also influenced the loss of kidney function. This new genetic interaction model needs to be confirmed in future studies...
  7. ncbi request reprint Effect of short-term hyperglycaemia on haemodynamics in type 1 diabetic patients
    P Jacobsen
    Steno Diabetes Center, Gentofte, Denmark
    J Intern Med 254:464-71. 2003
    ..We tested the impact of short-term hyperglycaemia on systemic blood pressure and regulatory hormones in type 1 diabetic patients...
  8. ncbi request reprint Dual blockade of the renin-angiotensin system versus maximal recommended dose of ACE inhibition in diabetic nephropathy
    Peter Jacobsen
    Steno Diabetes Center, Gentofte, Denmark
    Kidney Int 63:1874-80. 2003
    ....
  9. ncbi request reprint Additive effect of ACE inhibition and angiotensin II receptor blockade in type I diabetic patients with diabetic nephropathy
    Peter Jacobsen
    Steno Diabetes Center, Gentofte, Denmark and Faculty of Health Science, University of Aarhus, Denmark
    J Am Soc Nephrol 14:992-9. 2003
    ..All treatments were safe and well tolerated. In conclusion, dual blockade of the RAS may offer additional renal and cardiovascular protection in type I diabetic patients with DN...
  10. doi request reprint Effect of adjunct metformin treatment on levels of plasma lipids in patients with type 1 diabetes
    S S Lund
    Steno Diabetes Center, Niels Steensens Vej 2, 2820 Gentofte, Denmark
    Diabetes Obes Metab 11:966-77. 2009
    ..In this study, we report the effect of a 1-year treatment with metformin vs. placebo on plasma lipids in T1DM patients and persistent poor glycaemic control...
  11. ncbi request reprint Impact of renin angiotensin system blockade on night to day blood pressure ratio in diabetic nephropathy
    Peter Karl Jacobsen
    Nephrol Dial Transplant 21:2030-1. 2006